Literature DB >> 9636556

Bone marrow augmentation in renal transplant recipients.

R Shapiro1, T E Starzl.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9636556      PMCID: PMC2954780          DOI: 10.1016/s0041-1345(98)00279-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  37 in total

1.  Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.

Authors:  A P Monaco; J J Gozzo; M L Wood; A Liegeois
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

2.  Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.

Authors:  M L Wood; A P Monaco; J J Gozzo; A Liegeois
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

3.  Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.

Authors:  M L Wood; J J Gozzo; A P Monaco
Journal:  Transplant Proc       Date:  1972-12       Impact factor: 1.066

4.  Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.

Authors:  A P Monaco; M L Wood
Journal:  Transplant Proc       Date:  1970-12       Impact factor: 1.066

5.  Use of antilymphocyte serum in the induction of immunological tolerance to tissue allografts.

Authors:  A P Monaco
Journal:  Fed Proc       Date:  1970 Jan-Feb

6.  Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism.

Authors:  R Shapiro; A S Rao; P Fontes; M Jordan; V P Scantlebury; C Vivas; A J Demetris; A Zeevi; W Rybka; P Carroll
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

7.  Combined bone marrow and whole organ transplantation from the same donor.

Authors:  A S Rao; P Fontes; A Zeevi; M Trucco; R Shapiro; A J Demetris; A G Tzakis; P B Carroll; W A Rudert; F S Dodson
Journal:  Transplant Proc       Date:  1994-12       Impact factor: 1.066

8.  Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.

Authors:  J M Thomas; F M Carver; M B Foil; W R Hall; C Adams; G B Fahrenbruch; F T Thomas
Journal:  Transplantation       Date:  1983-07       Impact factor: 4.939

9.  Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt.

Authors:  A P Monaco; A W Clark; M L Wood; A I Sahyoun; S D Codish; R W Brown
Journal:  Surgery       Date:  1976-04       Impact factor: 3.982

10.  Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts.

Authors:  S Slavin; S Strober; Z Fuks; H S Kaplan
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  5 in total

1.  Kidney transplantation with bone marrow augmentation: five-year outcomes.

Authors:  R Shapiro; A S Rao; R J Corry; M Valenti; A Zeevi; M L Jordan; V P Scantlebury; C A Vivas; A Jain; J McCauley; P Randhawa; E A Gray; I Dvorchik; J McMichael; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

3.  Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.

Authors:  R J Corry; P K Chakrabarti; R Shapiro; A S Rao; I Dvorchik; M L Jordan; V P Scantlebury; C A Vivas; J J Fung; T E Starzl
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

4.  Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease following renal transplantation.

Authors:  Tomohiro Aoki; Masanobu Kasai; Yasuhiko Harada; Erina Matsubara; Takanobu Morishita; Tatsuya Suzuki; Makoto Tsujita; Norihiko Goto; Akio Katayama; Yoshihiko Watarai; Kazuharu Uchida; Masafumi Ito; Hiroo Saji; Toyonori Tsuzuki; Toshiki Uchida; Michinori Ogura
Journal:  Int J Hematol       Date:  2013-05-11       Impact factor: 2.490

5.  Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.

Authors:  Ghasem Solgi; Vijayakrishna Gadi; Biswajit Paul; Joannis Mytilineos; Gholamreza Pourmand; Abdolrasoul Mehrsai; Moslem Ranjbar; Mousa Mohammadnia; Behrouz Nikbin; Ali Akbar Amirzargar
Journal:  Chimerism       Date:  2013-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.